Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Azumino
Clinical trial register · Japan

Clinical Trials in Azumino, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2499 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:19 UTC
2499
Studies in scope
all four open statuses
1270
Recruiting now
open to new participants
351
Lead sponsors
across recruiting studies
Top sites
Fukuoka 555 Nagoya 517 Sapporo 399 Tokyo 370 Osaka 351
Narrow the registerReset
Recruitment status
Phase
Site location
Fukuoka555 Nagoya517 Sapporo399 Tokyo370 Osaka351
All 927 locations
Target enrolment
to

Trials with a site in Azumino

8 of 2499 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Sanofi
Phase 3
723
Nagoya, Sapporo, Kobe, Yokohama, Azumino, Shimajiri, Iruma, Koshigaya
2025-08-06
Recruiting
Close Collaboration and Discharge Readiness
NCT06057974Family Centered Care
Nagano Children's Hospital
Observational
60
Azumino
2023-09-28
Active, closed
Rhythm Pharmaceuticals, Inc.
Phase 3
143
Nagoya, Azumino, Minato
2023-04-26
Recruiting
Pfizer
Phase 3
100
Kobe, Azumino, Kashihara, Saga, Saitama-shi
2022-12-09
Recruiting
Pfizer
Phase 3
245
Nagoya, Azumino, Kashihara, Lruma-gun, Saitama-shi, Hiroshima, Saga
2021-11-17
Active, closed
Nagano Children's Hospital
Observational
90
Azumino
2021-02-01
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Azumino, Kurashiki-shi, Kawagoe-shi, Saitama, Tokyo, Izumi
2019-05-09
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
NCT05685745Infant, Extremely Premature, Obstetric Labor, Premature, Premature Birth, Intensive Care, Neonatal
The University of Texas Health Science Center, Houston
Observational
5,000
Shinkawa, Azumino, Izumi, Kawagoe, Shimotsuke, Tokyo
2019-01-01
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-japan/city/azumino

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,499 studies in total at the last sync on 28 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Azumino.

How many clinical trials are recruiting in Azumino?

5 of the 8 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Azumino), 8 studies
PhaseStudiesRecruitingShare
Phase 34350%
Observational3237.5%
Phase 21012.5%

Most active sponsors

Lead sponsors with the most studies (Azumino)
Lead sponsorStudiesRecruiting
Nagano Children's Hospital21
Pfizer22
OHB Neonatology Ltd.10
Rhythm Pharmaceuticals, Inc.10
Sanofi11
The University of Texas Health Science Center, Houston11
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.